Substance Use Disorders in Hospital Care

What This ECHO Will Focus On

This 12 session ECHO series will help build or improve care systems to effectively treat addiction in a hospital setting. Topics may include:

Understanding Substance Use Disorder (SUD): Brain disease of addiction	Medications for Opioid Use Disorder, including buprenorphine and methadone
Managing Alcohol & Methamphetamine Use Disorders in hospital care	Community SUD treatment settings
Acute pain management in a patient with SUD	Managing active drug use in the hospital
Peers in hospital settings	Overdose prevention and harm reduction as part of hospital care
Trauma Informed Care

Hospital clinicians (prescribing MD, DO, NP, PAs), nurses, social workers, pharmacists, discharge planners, behavioral health specialists, administrators, and quality improvement specialists are encouraged to register. Ideally staff will participate as part of a hospital-based team that includes a clinician and one or more other staff member. Participants will be selected based on their interest and geographic distribution throughout Oregon.

*Accreditation
Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians

Credit: OHSU School of Medicine designates this live activity for a maximum 12.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is registered for MOC through the American Board of Internal Medicine (ABIM)

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Substance Use Disorder in Hospital Care has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: Family Medicine, Psychiatry and Neurology, and Preventive Medicine

FACULTY DISCLOSURE INFORMATION
In accordance with the requirements of the Standards for Commercial Support of the Accreditation Council for Continuing Medical Education, each instructor and member of the planning committee has been asked to disclose any relevant financial relationships with commercial interests (defined as: any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients). The information disclosed for this activity is listed below.

PROGRAM PLANNING COMMITTEE

Honora Englander, M.D., F.A.C.P.: Nothing to Disclose
Jessica Gregg, M.D., Ph.D.: Nothing to Disclose

INSTRUCTORS/MODERATORS

Basilia Basin, Ph.D., R.N.: Nothing to Disclose	Jessica Gregg, M.D., Ph.D.: Nothing to Disclose
Honora Englander, M.D., F.A.C.P.: Nothing to Disclose	Ximena Levander, M.D.: Nothing to Disclose
Amelia Goff, NP: Nothing to Disclose	Susannah Lujan-Bear, MSN, RN: Nothing to Disclose
Traci Lundy, IPS, PSS, PWS: Nothing to Disclose	Kate Marshall, MD: Nothing to Disclose
Stacey Mahoney, L.C.S.W., C.A.D.C. II: Nothing to Disclose	Emily Skogrand, PharmD: Nothing to Disclose
Juliana Wallace, LCSW: Nothing to Disclose	Lisa Whitmore, RN, BC-FNP: Nothing to Disclose

End Date

6/30/2021

Session/Title	Date
0 - General Resources	2/1/2021
1 - ECHO Introduction and Basics	4/7/2021
2 - Buprenorphine in Hospital Care	4/14/2021
3 - Methadone in Hospital Care	4/21/2021
4 - Trauma Informed Care in a Hospital Setting	4/28/2021
5 - Difficult Conversations	5/5/2021
6 - Harm Reduction and Overdose Prevention	5/12/2021
7 - Medications for Alcohol Use Disorder	5/19/2021
8 - Methamphetamine Use Disorder	5/26/2021
9 - Peer Perspectives on Hospital Care	6/2/2021
10 - Community SUD Treatment Settings	6/9/2021
11 - Acute pain in the Setting of Opioid Use Disorder	6/16/2021
12 - Organizational Buy-in for System Level Change	6/23/2021
13 - Participant Debrief	6/30/2021